Skip to main content
OpenTrials

Clinical trial condition

Primary Immune Deficiency

Explore clinical trials studying Primary Immune Deficiency. Study availability and eligibility vary by location and protocol.

17 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Primary Immune Deficiency trial results

Completed

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

NCT01199705

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Study site Nagoya, Aichi Pref., Japan
  • Study site Chiba, Chiba Pref., Japan
  • Study site Gifu, Gifu Pref., Japan
  • Study site Sapporo, Hokkaido, Japan
View Trial Details
Completed

Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)

NCT01461018

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Study site Nagoya, Aichi Pref., Japan
  • Study site Chiba, Chiba Pref., Japan
  • Study site Fukuoka, Japan
  • Study site Gifu, Gifu Pref., Japan
View Trial Details
Completed

Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)

NCT00719680

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Contact CSL Behring for facility details Centennial, Colorado, United States
  • Contact CSL Behring for facility details North Palm Beach, Florida, United States
  • Contact CSL Behring for facility details Indianapolis, Indiana, United States
  • Contact CSL Behring for facility details Dallas, Texas, United States
View Trial Details
Completed

Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency

NCT00680446

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Campbelltown Hospital Campbelltown, New South Wales, Australia
  • Sydney Children's Hospital Randwick, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Women's & Children's Hospital North Adelaide, South Australia, Australia
View Trial Details
Completed

Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy

NCT00419341

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Study Site Los Angeles, California, United States
  • Study Site Los Angeles, California, United States
  • Study Site Centennial, Colorado, United States
  • Study Site North Palm Beach, Florida, United States
View all 13 locations
View Trial Details
Completed

Retrospective Chart Review of Subcutaneous IgG Use in Infants

NCT01166074

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of South Florida Tampa, Florida, United States
  • Midwest Immunology Clinic Plymouth, Minnesota, United States
  • University Hospitals Case Medical Center Cleveland, Ohio, United States
View Trial Details

Related conditions